Kraig Biocraft Laboratories, Inc. (KBLB) › Operating Cash FlowKraig Biocraft Laboratories, Inc. (KBLB) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2010: -$195.4K2011: -$556.1K2012: -$562.9K2013: -$800.2K2014: -$904.6K2015: -$967.6K2016: -$1.01M2017: -$729.5K2018: -$235.0K2019: -$1.09M2020: -$1.25M2021: -$1.80M2022: -$1.89M2023: -$1.24M2024: -$1.84M2025: -$1.79M-$1.79M2010Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$1.79M+2.7%2024-$1.84M-47.8%2023-$1.24M+34.1%2022-$1.89M-4.8%2021-$1.80M-43.5%2020-$1.25M-15.3%2019-$1.09M-362.9%2018-$235.0K+67.8%2017-$729.5K+27.9%2016-$1.01M-4.6%2015-$967.6K-7.0%2014-$904.6K-13.0%2013-$800.2K-42.1%2012-$562.9K-1.2%2011-$556.1K-184.5%2010-$195.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share